SM
CYTO
Sabby Management’s Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) CYTO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-89,451
| Closed | -$72K | – | 90 |
|
|
2020
Q1 | $72K | Sell |
89,451
-82,432
| -48% | -$66.4K | 0.03% | 46 |
|
|
2019
Q4 | $278K | Buy |
171,883
+4,383
| +3% | +$7.09K | 0.08% | 25 |
|
|
2019
Q3 | $461K | Buy |
167,500
+43,910
| +36% | +$121K | 0.25% | 26 |
|
|
2019
Q2 | $342K | Buy |
+123,590
| New | +$342K | 0.43% | 31 |
|
|
2018
Q3 | – | Sell |
-263,625
| Closed | -$206K | – | 109 |
|
|
2018
Q2 | $206K | Sell |
263,625
-79,364
| -23% | -$62K | 0.03% | 56 |
|
|
2018
Q1 | $549K | Buy |
+342,989
| New | +$549K | 0.07% | 45 |
|
|
2017
Q3 | – | Sell |
-143,800
| Closed | -$103K | – | 149 |
|
|
2017
Q2 | $103K | Sell |
143,800
-1,100
| -0.8% | -$788 | 0.01% | 96 |
|
|
2017
Q1 | $133K | Buy |
+144,900
| New | +$133K | 0.01% | 112 |
|